Boston Scientific Corp (BSX) Stock Price, Quote & News

Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal sur...

Industry: Medical Devices

Sector: Healthcare

Phone: 508 683 4000

Website: www.bostonscientific.com

Address:

300 Boston Scientific Way, Marlborough, United States

smartkarma Jun. 21 at 8:02 PM

$BSX | Boston Scientific WATCHMAN Surge: Will 20% Growth & New Clinical Data Cement Its Cardiovascular Dominance? "Boston Scientific Corporation reported strong first quarter 2025 results, exhibiting significant growth in both revenue and earnings. The..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/boston-scientific-watchman-surge-will-20-growth-new-clinical-data-cement-its-cardiovascular-dominance

0 · Reply

IN0V8 Jun. 20 at 2:55 PM

$BSX Buy Jefferies raises target price to $125 from $122

0 · Reply

SteveJohnsonis Jun. 19 at 1:07 PM

$BSX

0 · Reply

ZacksResearch Jun. 18 at 3:27 PM

$BSX: Neuromodulation driving growth, but is it a buy? 🤔 📈 Neuromodulation sales up 6.8% YoY in Q1’25, with Pain franchise gaining high-single digits and Brain franchise growing mid-single digits. 🔍 Shares up 33.3% in a year, beating industry & S&P 500. 📊 Valuation at 33.11x P/E vs. industry’s 21.09x raises questions. Full analysis here 👉 https://www.zacks.com/commentary/2510467/bsxs-neuromodulation-arm-sees-growth-q1-highlights?cid=sm-stocktwits-2-2510467-body&ADID=SYND_STOCKTWITS_TWEET_2_2510467_BODY

0 · Reply

ZacksResearch Jun. 18 at 3:13 PM

$ISRG vs. $BSX: Who's the Smart Med-Tech Bet? 🤔 Intuitive Surgical's da Vinci system projects 15-17% procedure growth for the year, but tariff risks loom. Meanwhile, Boston Scientific shines with strong cardiovascular sales and a 13.9% YTD stock gain, despite a more leveraged profile. Full analysis on which stock deserves a spot in your portfolio 👉 https://www.zacks.com/commentary/2510368/isrg-vs-bsx-which-medical-device-stock-has-more-room-to-run?cid=sm-stocktwits-2-2510368-body&ADID=SYND_STOCKTWITS_TWEET_2_2510368_BODY

0 · Reply

Quantumup Jun. 18 at 2:23 PM

Truist reiterated $PRCT Buy-$70. $BSX $ISRG $MDT $TNDM SYK Truist said in its note: "We believe gdce continues to leave room for upside given mgmt. commentary (a) it's trying to be conservative (still early in yr) (b) healthy March utilization momentum is carrying over into April/May, and (c) CFO Waters continues to emphasize a high degree of confidence on capital pipeline leads as well as increasingly predictable capital conversions (helped by more IDN placements). Mgmt. sees handpiece gdce continuing to set-up for beat & raises, and the decision to exercise "restraint"---holding back a bigger initial raise following the 1Q handpiece upside---was made in this vein (to guide conservatively early in the year)."

0 · Reply

ZacksResearch Jun. 18 at 2:22 PM

$BSX’s brain and pain therapies just delivered a Q1 jolt 📈 Neuromodulation segment grew 6.8%, with pain and brain therapy driving the upside. See what’s powering the growth engine here 👉 https://www.zacks.com/stock/news/2510467/bsxs-neuromodulation-arm-sees-growth-q1-highlights?cid=sm-stocktwits-2-2510467-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2510467_TEASER

0 · Reply

ZacksResearch Jun. 18 at 12:55 PM

$ISRG vs $BSX — Which one’s the real long-term winner? BSX brings consistent growth and diversified exposure, but ISRG's edge in robotics is clouded by margin pressure and tariff risks. Opportunity breakdown here 👉 https://www.zacks.com/stock/news/2510368/isrg-vs-bsx-which-medical-device-stock-has-more-room-to-run?cid=sm-stocktwits-2-2510368-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2510368_TEASER

0 · Reply

ElliottwaveForecast Jun. 18 at 8:48 AM

$BSX favors a rally in a bullish sequence, targeting 120+ Short-term pullbacks should stay supported above the daily #BlueBox area. Full analysis 👉 https://elliottwave-forecast.com/stock-market/bsx-navigating-market-trends-price-action/ #ElliottWave #Stocks

0 · Reply

PivotMasterAI_com Jun. 17 at 2:19 PM

🚨 $BSX — BOUNCE MODE ACTIVATED. PivotMasterAI Just Fired. 🚨 Fresh off a textbook pullback to the bottom Bollinger Band, PivotMasterAI just issued a BUY on Boston Scientific — and if you’ve followed this setup before, you know what comes next. 📈🔥 This isn’t noise — this is calculated reversal territory with system-level confirmation. Let’s break it down 👇 📊 $BSX Strategy Snapshot (Ver 3.6): ✅ +24.59% Total P&L ✅ $265,900 in net gains ✅ 60% Win Rate – consistent performance across 75 trades ✅ Profit Factor: 1.672 – solid edge ⚠️ Drawdown: 14.81% – size smart, manage risk ⭐ Strategy Rating: 55 – proven but selective ✅ CAGR: 10.04% – long-term steady builder 📍 The setup? Price touched lower Bollinger Band SQZMOM momentum is starting to flip Green candle confirmed at key support BUY signal fired right at the pivot zone 🧠 This is where smart traders start building. PivotMasterAI doesn't guess — it triggers when the math makes sense. 🔔 Remember: Dozens of these alerts hit the PivotMasterAI radar every day. $BSX just lit up for a reason. The system likes the odds — and we like the risk/reward. #BSX #BostonScientific #PivotMasterAI #BuySignal #SwingTrade #MeanReversion #BollingerBounce #AITrading #SmartEntries #WeGetSignalsDaily #CalculatedMoves #ChartWithEdge

0 · Reply

I'm Buying Dividend Aristocrats At Bargain Basement Prices

JNJ KO MDT PEP

Jun 16, 2025, 11:00 AM EDT - 6 days ago

What's Happening With Boston Scientific Stock?

Jun 10, 2025, 10:53 AM EDT - 12 days ago

20 stocks bucking bad trends on Wall Street — what might be next for them?

AMT ANET AVGO TRMB BAC C CCL

Jun 6, 2025, 2:42 PM EDT - 16 days ago

3 Growth Stocks That Aren't the Magnificent 7

CYBR

May 30, 2025, 4:45 AM EDT - 23 days ago

Boston Scientific: Old, Reliable; Buy For Their Consistent Growth

May 28, 2025, 3:40 PM EDT - 25 days ago

Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook

May 28, 2025, 12:14 PM EDT - 25 days ago

Boston Scientific Corporation (BSX) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

May 28, 2025, 8:09 AM EDT - 25 days ago

Boston Scientific to not seek US approval for heart device amid regulatory challenges

May 13, 2025, 3:33 PM EDT - 5 weeks ago

Boston Scientific Corporation (BSX) Bank of America's 2025 Health Care Conference (Transcript)

May 1, 2025, 8:00 AM EDT - 7 weeks ago

Boston Scientific announces upcoming investor conference schedule

Apr 29, 2025, 11:30 AM EDT - 7 weeks ago

Baron Health Care Fund Q1 2025 Top Contributors And Detractors

ACLX DHR GKOS INSM ISRG LLY RDNT

Apr 24, 2025, 3:41 PM EDT - 2 months ago

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints

Apr 24, 2025, 2:13 PM EDT - 2 months ago

Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results

Apr 23, 2025, 11:34 AM EDT - 2 months ago

Boston Scientific Corporation (BSX) Q1 2025 Earnings Call Transcript

Apr 23, 2025, 10:22 AM EDT - 2 months ago

Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO Transition

Apr 23, 2025, 9:56 AM EDT - 2 months ago

Boston Scientific Stock Surges on Strong Results, Outlook; CFO To Retire

Apr 23, 2025, 8:11 AM EDT - 2 months ago

Boston Scientific raises 2025 profit forecast on strong heart device sales

Apr 23, 2025, 6:45 AM EDT - 2 months ago

Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan

Apr 23, 2025, 6:30 AM EDT - 2 months ago

Boston Scientific announces results for first quarter 2025

Apr 1, 2025, 4:35 PM EDT - 2 months ago

Goldman Sachs Thinks These Stocks Are ‘Insulated' From a Trade War

PCG

Apr 1, 2025, 8:00 AM EDT - 2 months ago

Boston Scientific announces conference call discussing first quarter 2025 results

Mar 4, 2025, 1:00 PM EST - 3 months ago

Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript)

Mar 3, 2025, 6:58 AM EST - 3 months ago

Boston Scientific announces agreement to acquire SoniVie Ltd.

Feb 26, 2025, 4:15 PM EST - 4 months ago

Boston Scientific announces completion of €1.5 billion offering of senior notes

Feb 24, 2025, 11:50 AM EST - 4 months ago

Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System

Feb 21, 2025, 9:35 PM EST - 4 months ago

Boston Scientific announces pricing of €1.5 billion of senior notes

Feb 19, 2025, 8:00 AM EST - 4 months ago

Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference

Feb 12, 2025, 7:00 AM EST - 4 months ago

What's Behind The 130% Rise In BSX Stock?

Feb 5, 2025, 11:31 AM EST - 4 months ago

Boston Scientific Corporation (BSX) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 7:56 AM EST - 4 months ago

Boston Scientific sees higher-than-expected 2025 profit on strong demand

Feb 5, 2025, 6:37 AM EST - 4 months ago

Boston Scientific announces results for fourth quarter and full year 2024

Jan 21, 2025, 6:06 AM EST - 5 months ago

Top 4 Health Care Stocks You May Want To Dump In Q1

BBIO ISRG ITCI

Jan 16, 2025, 5:33 PM EST - 5 months ago

Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation

Jan 15, 2025, 6:10 AM EST - 5 months ago

Boston Scientific Jumps Ahead of Earnings

Jan 10, 2025, 1:13 PM EST - 5 months ago

Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific

CEG DAL SG WYNN

Jan 8, 2025, 2:07 PM EST - 5 months ago

Final Trades: Apollo, UnitedHealth, Boston Scientific and the IYF

UNH APO IYF

Jan 8, 2025, 12:25 PM EST - 5 months ago

Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal

Jan 8, 2025, 7:00 AM EST - 5 months ago

Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.

Jan 2, 2025, 8:00 AM EST - 6 months ago

Boston Scientific Announces Participation in the J.P. Morgan Healthcare Conference and Conference Call Discussing Fourth Quarter 2024 Results

Dec 31, 2024, 8:55 AM EST - 6 months ago

Boston Scientific Corporation: Solid Financials And Upward Continuation

Dec 18, 2024, 4:16 PM EST - 6 months ago

FDA classifies recall of Boston Scientific catheters as 'most serious'

Dec 11, 2024, 8:08 AM EST - 6 months ago

Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace

Dec 9, 2024, 7:33 PM EST - 6 months ago

Jim Cramer talks companies that joined the $100 billion club this year

ANET APP ARM C ETN FI PANW

Nov 25, 2024, 7:00 AM EST - 7 months ago

Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.

Nov 18, 2024, 12:15 PM EST - 7 months ago

Why Is Medical Device Giant Boston Scientific Stock Trading Higher On Monday?

Nov 16, 2024, 3:07 PM EST - 7 months ago

Boston Scientific WATCHMAN FLX™ Left Atrial Appendage Closure Device Demonstrates Superior Bleeding Risk Reduction to Oral Anticoagulation Following a Cardiac Ablation in the OPTION Clinical Trial

Nov 15, 2024, 3:08 PM EST - 7 months ago

Boston Scientific Corporation (BSX) UBS Global Healthcare Conference (Transcript)

Nov 15, 2024, 8:43 AM EST - 7 months ago

Boston Scientific Closes Acquisition of Axonics, Inc.

AXNX

Nov 7, 2024, 9:19 AM EST - 8 months ago

Kidney Stone Management Market Forecast Report, 2024-2032 - Cook Group, Richard Wolf, Boston Scientific, and Dornier MedTech Actively Engaged in M&As to Increase Share

Nov 5, 2024, 8:00 AM EST - 8 months ago

Boston Scientific to Participate in the 2024 UBS Global Healthcare Conference

smartkarma Jun. 21 at 8:02 PM

0 · Reply

IN0V8 Jun. 20 at 2:55 PM

$BSX Buy Jefferies raises target price to $125 from $122

0 · Reply

SteveJohnsonis Jun. 19 at 1:07 PM

$BSX

0 · Reply

ZacksResearch Jun. 18 at 3:27 PM

0 · Reply

ZacksResearch Jun. 18 at 3:13 PM

0 · Reply

Quantumup Jun. 18 at 2:23 PM

0 · Reply

ZacksResearch Jun. 18 at 2:22 PM

0 · Reply

ZacksResearch Jun. 18 at 12:55 PM

0 · Reply

ElliottwaveForecast Jun. 18 at 8:48 AM

0 · Reply

PivotMasterAI_com Jun. 17 at 2:19 PM

0 · Reply

Dr_Stoxx Jun. 17 at 1:27 PM

$BSX picks up an "outperform" rating. 118 PT.

0 · Reply

IN0V8 Jun. 16 at 8:28 PM

$BSX Leerink Partners initiates coverage with outperform rating Leerink Partners initiates coverage with target price $118

0 · Reply

StocktwitsNews Jun. 16 at 5:30 PM

Leerink Initiates Boston Scientific Coverage With ‘Outperform’ Rating: Stock Rallies But Retail’s Not Overly Excited $BSX $VTI $VOO https://stocktwits.com/news/equity/markets/leerink-initiates-boston-scientific-coverage-with-outperform-rating/chlnU3QRRRw

0 · Reply

trading_momentum Jun. 16 at 1:23 PM

Analyst Ratings: Medtronic $MDT initiated as BUY by Leerink Partners, target $110 (24.83% upside). Boston Scientific $BSX initiated as BUY, target $118 (18.31% upside). Martin Marietta $MLM initiated as HOLD by RBC Capital, target $515 (-5.07% downside). Economic Data: NY Fed Manufacturing Index fell to -16.0 in June, worse than the expected -6.3, signaling manufacturing weakness. Market Risks: RBC warns U.S. stocks risk a 20% drop in a high inflation scenario. Morgan Stanley raised oil forecasts by up to $10 due to Middle East tensions, potentially impacting markets. Crypto & ETFs: Truth Social filed for Bitcoin and Ethereum ETFs. MicroStrategy $MSTR bought 10,100 BTC between June 9-15.

0 · Reply

JarvisFlow Jun. 16 at 12:00 PM

Leerink Partners has adjusted their stance on Boston Scientific ( $BSX ), setting the rating to Outperform with a target price of 118.

0 · Reply

hen Jun. 13 at 11:58 PM

$BSX know a girl that is on her way to Israel to get a product line going for BSC. Terrible timing lol

0 · Reply

jewell69 Jun. 13 at 6:10 PM

tryin 2 buy $EPOL 29.90 6/13 2:09 pm edt fwiw: in 1 of our accounts, only up: $BSX

0 · Reply

zoey1970 Jun. 13 at 3:21 PM

$MDT How Next-Gen Implants Are Making Seizure Prevention Smarter and Safer Than Ever An implantable chip could soon spot early epilepsy signals and intervene, significantly enhancing patients’ quality of life. At the heart of this innovation are Spiking Neural Networks (SNNs), a form of artificial intelligence that mimics the brain’s efficiency. These neuromorphic implantables, built on SNNs, mark notable progress toward energy-efficient AI, contrasting with traditional Artificial Neural Networks (ANNs) that operate nonstop like constant light sources. SNNs, in contrast, utilize event-triggered “spikes” (brief electrical pulses), activating only as needed and thereby slashing energy use—a vital advantage for medical tools. Read more here if interested...https://neuromorphiccore.ai/how-next-gen-implants-are-making-seizure-prevention-smarter-and-safer-than-ever/ $BSX $ABT $NPCE $LIVN

0 · Reply

ZacksResearch Jun. 13 at 1:49 PM

$BSX riding the endoscopy wave — can it sustain the momentum? 🌊 Sales of Endoscopy products totaled $673 million, up 6% both operationally and organically, for the first quarter of 2025, accounting for 14% of the company’s overall revenues. Double-digit growth from innovative products like AXIOS and the Endoluminal Surgery franchise's OverStitch driving strong adoption. 📈 But with a forward P/E of 32.13X, it's trading above industry averages. Explore more: https://www.zacks.com/commentary/2497837/bsx-q1-endoscopy-sales-rise-6-whats-behind-the-growth?cid=sm-stocktwits-2-2497837-body&ADID=SYND_STOCKTWITS_TWEET_2_2497837_BODY

0 · Reply

ZacksResearch Jun. 13 at 11:53 AM

$BSX Endoscopy sales up 6% in Q1 — what's driving the move? Growth fueled by innovation in stents, clips, and GI surgical tools — a strong signal of product momentum in a competitive space. Full breakdown here 👉 https://www.zacks.com/stock/news/2497837/bsx-q1-endoscopy-sales-rise-6-whats-behind-the-growth?cid=sm-stocktwits-2-2497837-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2497837_TEASER

0 · Reply

TradeInYourJob Jun. 13 at 12:33 AM

$BSX Looks like lots more downside risk ahead based on CCI and onbalance volume.

0 · Reply

TwoToesTrading Jun. 12 at 7:53 PM

$BSX $GME $MSTR $CC flow

0 · Reply

Market Cap	149.87B
Revenue (ttm)	16.75B
Net Income (ttm)	1.85B
EPS (ttm)	N/A
PE Ratio	37.52
Forward PE	34.78
Profit Margin	11.07%
Debt to Equity Ratio	0.50

Volume	11,349,600
Avg Vol	7,886,666
Day's Range	N/A - N/A
Shares Out	1.48B
Stochastic %K	75%
Beta	0.68
Analysts	Strong Sell
Price Target	$120.40